Caxton Associates (New York)’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-9,811
| Closed | -$617K | – | 529 |
|
2024
Q3 | $617K | Buy |
+9,811
| New | +$617K | 0.02% | 328 |
|
2023
Q3 | – | Sell |
-8,926
| Closed | -$617K | – | 446 |
|
2023
Q2 | $617K | Sell |
8,926
-696
| -7% | -$48.1K | 0.09% | 229 |
|
2023
Q1 | $715K | Buy |
9,622
+1,607
| +20% | +$119K | 0.11% | 199 |
|
2022
Q4 | $747K | Buy |
+8,015
| New | +$747K | 0.05% | 155 |
|
2021
Q2 | – | Sell |
-10,120
| Closed | -$761K | – | 462 |
|
2021
Q1 | $761K | Buy |
+10,120
| New | +$761K | 0.07% | 83 |
|
2020
Q3 | – | Sell |
-6,453
| Closed | -$419K | – | 341 |
|
2020
Q2 | $419K | Buy |
6,453
+143
| +2% | +$9.29K | 0.04% | 157 |
|
2020
Q1 | $374K | Sell |
6,310
-70,390
| -92% | -$4.17M | 0.07% | 208 |
|
2019
Q4 | $5.7M | Buy |
+76,700
| New | +$5.7M | 0.78% | 16 |
|
2018
Q3 | – | Sell |
-6,542
| Closed | -$421K | – | 383 |
|
2018
Q2 | $421K | Sell |
6,542
-10,703
| -62% | -$689K | 0.02% | 226 |
|
2018
Q1 | $1.07M | Buy |
17,245
+2,502
| +17% | +$156K | 0.05% | 136 |
|
2017
Q4 | $1.07M | Buy |
14,743
+10,943
| +288% | +$793K | 0.05% | 153 |
|
2017
Q3 | $309K | Buy |
+3,800
| New | +$309K | 0.01% | 382 |
|
2015
Q2 | – | Sell |
-4,000
| Closed | -$413K | – | 133 |
|
2015
Q1 | $413K | Buy |
+4,000
| New | +$413K | 0.02% | 119 |
|
2014
Q3 | – | Hold |
0
| – | – | – | 166 |
|
2014
Q2 | – | Hold |
0
| – | – | – | 167 |
|
2013
Q3 | – | Sell |
-45,000
| Closed | -$2.57M | – | 155 |
|
2013
Q2 | $2.57M | Buy |
+45,000
| New | +$2.57M | 0.13% | 84 |
|